Mediastinal Staging for Lung Cancer | Zendy

Jacob Gelberg | Zendy; Sean Grondin | Zendy; Alain Tremblay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mediastinal Staging for Lung Cancer

Author(s) -

Jacob Gelberg,

Sean Grondin,

Alain Tremblay

Publication year - 2014

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2014/890108

Subject(s) - medicine , lung cancer , radiology , lung cancer staging , positron emission tomography , mediastinoscopy , cancer staging , lymph , mediastinum , computed tomography , cancer , pet ct , modalities , pathology , social science , sociology

Staging of the mediastinal and hilar lymph nodes plays a crucial role in identifying the best treatment option for patients with confirmed or suspected lung cancer and, in many cases, can simultaneously confirm a diagnosis of cancer. Noninvasive modalities, such as computed tomography (CT), positron emission tomography (PET) and PET-CT, are an important first step in this assessment. Ultimately, invasive staging is frequently required to confirm or rule out the presence of metastatic disease within the lymph nodes. The present focused review describes and compares noninvasive and invasive modalities for mediastinal staging in lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research